Phase II Prospective Study of Trastuzumab in Combination with S-1 and Oxaliplatin (SOX100) Therapy for HER2-Positive Advanced Gastric Cancer.
Mori Y, Kataoka H, Ebi M, Adachi K, Yamaguchi Y, Hayashi N, Hirata Y, Sobue S, Ishihara R, Suzuki Y, Mizushima T, Inoue Y, Hasegawa I, Ono S, Hirano A, Kimura Y, Seno K, Ozeki K, Shimura T, Kubota E.
Mori Y, et al. Among authors: adachi k.
J Gastrointest Cancer. 2022 Dec;53(4):930-938. doi: 10.1007/s12029-021-00711-0. Epub 2021 Sep 22.
J Gastrointest Cancer. 2022.
PMID: 34550548
Clinical Trial.